ATAI Life Sciences N.V. (ATAI) Social Stream
ATAI LIFE SCIENCES NV (ATAI) Price Targets From Analysts
Use the tables below to see what analysts covering ATAI LIFE SCIENCES NV think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-02 | 9 | $45 | $19 | $31.571 | $2 | 1478.55% |
2021-11-16 | 10 | $45 | $19 | $31.625 | $2 | 1481.25% |
2021-11-18 | 10 | $45 | $17 | $31.375 | $2 | 1468.75% |
2021-11-22 | 10 | $50 | $17 | $32.625 | $2 | 1531.25% |
2022-01-19 | 11 | $50 | $17 | $31.777 | $2 | 1488.85% |
2022-01-20 | 11 | $50 | $17 | $29.222 | $2 | 1361.1% |
2022-04-01 | 11 | $50 | $17 | $28.555 | $2 | 1327.75% |
2022-04-05 | 11 | $50 | $9 | $27.555 | $2 | 1277.75% |
2022-05-20 | 11 | $50 | $9 | $26.111 | $2 | 1205.55% |
2022-06-01 | 11 | $50 | $9 | $25.7 | $2 | 1185% |
2022-08-16 | 8 | $50 | $9 | $24.444 | $2 | 1122.2% |
2022-08-18 | 7 | $50 | $9 | $24.444 | $2 | 1122.2% |
2022-10-28 | 9 | $50 | $9 | $24.222 | $2 | 1111.1% |
2022-11-18 | 10 | $50 | $9 | $23.6 | $2 | 1080% |
2022-12-16 | 9 | $50 | $9 | $23.545 | $2 | 1077.25% |
2023-01-06 | 10 | $50 | $7 | $21.727 | $2 | 986.35% |
2023-01-09 | 10 | $50 | $7 | $18.545 | $2 | 827.25% |
2023-01-19 | 9 | $27 | $7 | $13.2 | $2 | 560% |
2023-03-27 | 9 | $27 | $7 | $13.333 | $2 | 566.65% |
2023-03-28 | 9 | $27 | $6 | $13.222 | $2 | 561.1% |
2023-03-31 | 9 | $27 | $6 | $13.75 | $2 | 587.5% |
2023-05-15 | 9 | $27 | $2 | $13.25 | $2 | 562.5% |
2023-07-11 | 8 | $20 | $2 | $11.285 | $2 | 464.25% |
2023-08-14 | 7 | $20 | $6 | $11.857 | $2 | 492.85% |
2023-10-05 | 6 | $20 | $6 | $12.6 | $2 | 530% |
The Trend in the Analyst Price Target
ATAI's average price target has moved down $5.55 over the prior 38 weeks.
ATAI reports an average of 667.92% for its upside potential over the past 37 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2023-01-19 | 9 | 27 | 7 | 13.200 | 1.95 | 576.92% |
2023-05-15 | 9 | 20 | 2 | 11.285 | 2.00 | 464.25% |
2023-08-14 | 7 | 20 | 6 | 11.857 | 1.66 | 614.28% |
2023-08-14 | 8 | 20 | 6 | 12.166 | 1.66 | 632.89% |
2023-10-05 | 7 | 20 | 6 | 12.166 | 1.52 | 700.39% |
ATAI Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.33 | 5 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
ATAI's average broker recommendation rating improved by 0.53 over the prior 27 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how ATAI LIFE SCIENCES NV fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 3667.4% of that group.
- In the context of all US stocks, ATAI LIFE SCIENCES NV's variance in analysts' estimates is lower than -3482.86% of them.
- ATAI LIFE SCIENCES NV's average analyst price target is higher than 1134.19% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, ATAI LIFE SCIENCES NV's number of analysts covering the stock is greater than 2391.21% of them.
Stocks similar to ATAI LIFE SCIENCES NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ERAS, NUVL, and VTYX.
View All Top Stocks by Price Target
What is the outlook for ATAI? Use POWR Ratings for clearer insight into price direction.